Dinh Hoa Vu

1.2k total citations
41 papers, 767 citations indexed

About

Dinh Hoa Vu is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Dinh Hoa Vu has authored 41 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Pharmacology and 12 papers in Epidemiology. Recurrent topics in Dinh Hoa Vu's work include Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Dinh Hoa Vu is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Dinh Hoa Vu collaborates with scholars based in Vietnam, Netherlands and Australia. Dinh Hoa Vu's co-authors include Jan‐Willem C. Alffenaar, J. R. B. J. Brouwers, Donald R. A. Uges, Remco A. Koster, Thi Van Anh Nguyen, Richard Anthony, Anne‐Laure Bañuls, Ben Greijdanus, Mathieu S. Bolhuis and Richard van Altena and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Dinh Hoa Vu

38 papers receiving 759 citations

Peers

Countries citing papers authored by Dinh Hoa Vu

Since Specialization

Citations

This map shows the geographic impact of Dinh Hoa Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinh Hoa Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinh Hoa Vu more than expected).

Fields of papers citing papers by Dinh Hoa Vu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinh Hoa Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinh Hoa Vu. The network helps show where Dinh Hoa Vu may publish in the future.

Co-authorship network of co-authors of Dinh Hoa Vu

This figure shows the co-authorship network connecting the top 25 collaborators of Dinh Hoa Vu. A scholar is included among the top collaborators of Dinh Hoa Vu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinh Hoa Vu. Dinh Hoa Vu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Occurrence of multidrug-resistant Enterobacteriaceae and antibiotic-resistant genes in the anthropogenic impacted bay of Nha Trang, Viet Nam 2025 ·Regional Studies in Marine Science ·(unknown), Dinh Hoa Vu, Quang Dang Nguyen, (unknown), (unknown), Thi Thu Le, (unknown), (unknown), (unknown), (unknown), Anne‐Laure Bañuls, (unknown), Sylvain Théry, Yvan Bettarel, Jean‐Christophe Auguet, Quang Huy Nguyen	0
2	An mHealth app technology to strengthen adverse event management of multi‐drug‐resistant tuberculosis in Vietnam: Protocol for a process evaluation of the V‐SMART trial 2025 ·Tropical Medicine & International Health ·Hoa Binh Nguyen, (unknown), (unknown), (unknown), (unknown), Viet Nhung Nguyen, Dinh Hoa Vu, (unknown), (unknown), (unknown), Thu Anh Nguyen, Guy B. Marks, Joel Negin, Greg J. Fox, Sarah Bernays, H. Manisha Yapa	1
3	Metabolic phenotyping and global functional analysis facilitate metabolic signature discovery for tuberculosis treatment monitoring 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Nguyen Thi Hai Yen, (unknown), (unknown), (unknown), Ho-Sook Kim, Dinh Hoa Vu, Jee Youn Oh, Dong‐Hyun Kim, Nguyen Phuoc Long	3
4	Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice 2023 ·International Journal of Antimicrobial Agents ·(unknown), Quang Huy Nguyen, (unknown), Richard Anthony, Dinh Hoa Vu, Jan‐Willem C. Alffenaar	13
5	mHealth application for improving treatment outcomes for patients with multidrug-resistant tuberculosis in Vietnam: an economic evaluation protocol for the V-SMART trial 2023 ·BMJ Open ·Qinglu Cheng, (unknown), Thu Anh Nguyen, Kavindhran Velen, Viet Nhung Nguyen, Hoa Binh Nguyen, Dinh Hoa Vu, (unknown), (unknown), (unknown), Guy B. Marks, H. Manisha Yapa, Gregory J. Fox, Virginia Wiseman	1
6	Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review 2023 ·Clinical Pharmacokinetics ·(unknown), (unknown), (unknown), Dinh Hoa Vu, Yingda L. Xie, Monica Gandhi, Roy Gerona, John Metcalfe, Scott K. Heysell, Jan‐Willem C. Alffenaar	12
7	Optimizing Meropenem in Highly Resistant Klebsiella pneumoniae Environments: Population Pharmacokinetics and Dosing Simulations in Critically Ill Patients 2022 ·Antimicrobial Agents and Chemotherapy ·(unknown), Dao Xuan Co, Dinh Hoa Vu, Hoang Anh Nguyen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jeffrey Lipman, Menino Osbert Cotta, Jason A. Roberts	4
8	Harnessing new mHealth technologies to Strengthen the Management of Multidrug-Resistant Tuberculosis in Vietnam (V-SMART trial): a protocol for a randomised controlled trial 2022 ·BMJ Open ·Kavindhran Velen, Viet Nhung Nguyen, Hoa Binh Nguyen, (unknown), (unknown), Dinh Hoa Vu, (unknown), Pham Duc Cuong, (unknown), Pham Huu Thuong, Ben J. Marais, James C. Johnston, Warwick J. Britton, Justin Beardsley, Joel Negin, Virginia Wiseman, Guy B. Marks, Thu Anh Nguyen, Greg J. Fox	5
9	Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam 2022 ·Frontiers in Pharmacology ·(unknown), Hoa Binh Nguyen, Hoàng Thị Thanh Thủy, (unknown), Dinh Hoa Vu, (unknown), (unknown), Tom Decroo, Viet Nhung Nguyen	5
10	Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort study 2021 ·Journal of Infection and Chemotherapy ·(unknown), Dinh Hoa Vu, Hoang Anh Nguyen, Steven Abrams, Robin Bruyndonckx, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Samuel Coenen	5
11	Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam 2021 ·PLoS ONE ·(unknown), Dinh Hoa Vu, (unknown), (unknown), (unknown), (unknown), Hoang Anh Nguyen, (unknown), Hoa Binh Nguyen, Edine Tiemersma, Nguyen Viet Nhung	14
12	Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences 2019 ·European Respiratory Review ·Edine Tiemersma, Susan van den Hof, Gunta Dravniece, Fraser Wares, (unknown), (unknown), (unknown), (unknown), Si Thu Aung, (unknown), (unknown), Dinh Hoa Vu, (unknown), (unknown), (unknown), (unknown), (unknown)	2
13	Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis 2016 ·Expert Review of Clinical Pharmacology ·Thi Van Anh Nguyen, Thi Bich Tra Cao, Onno W. Akkerman, Simon Tiberi, Dinh Hoa Vu, (unknown)	22
14	Antibiotic therapy for inpatients with community‐acquired pneumonia in a developing country 2014 ·Pharmacoepidemiology and Drug Safety ·(unknown), Phuong H. Hoang, Magnolia Cardona, (unknown), (unknown), Dinh Hoa Vu, (unknown), (unknown), Son T. Nguyen, (unknown), (unknown), (unknown), Jonathan Dartnell, (unknown), (unknown)	7
15	Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS 2014 ·Talanta ·Dinh Hoa Vu, Remco A. Koster, Mathieu S. Bolhuis, Ben Greijdanus, Richard van Altena, (unknown), J. R. B. J. Brouwers, Donald R. A. Uges, Jan‐Willem C. Alffenaar	69
16	Troubleshooting carry-over of LC–MS/MS method for rifampicin, clarithromycin and metabolites in human plasma 2013 ·Journal of Chromatography B ·Dinh Hoa Vu, Remco A. Koster, A. Mireille A. Wessels, Ben Greijdanus, Jan‐Willem C. Alffenaar, Donald R. A. Uges	31
17	Relationship Between Azathioprine Dosage and Thiopurine Metabolites in Pediatric IBD Patients 2013 ·Therapeutic Drug Monitoring ·(unknown), Dinh Hoa Vu, (unknown), Alain Lachaux, Roselyne Boulieu	15
18	Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam 2012 ·The International Journal of Tuberculosis and Lung Disease ·Dinh Hoa Vu, Nienke van Rein, Frank Cobelens, Thi Thanh Huong Nguyen, (unknown), J. R. B. J. Brouwers	21
19	A review of the literature on the economics of vaccination against TB 2012 ·Expert Review of Vaccines ·(unknown), Dinh Hoa Vu, Mark H. Rozenbaum, Herman J. Woerdenbag, Maarten J. Postma	14
20	Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume 2011 ·Journal of Chromatography B ·Dinh Hoa Vu, Remco A. Koster, Jan‐Willem C. Alffenaar, J. R. B. J. Brouwers, Donald R. A. Uges	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact